新型藥丸有望治療多種不同類型的病毒
New pill could treat many different types of viruses
多年來，醫學界一直難以跟上病毒快速突變的步伐。
For years, medical science has struggled to keep pace with rapidly mutating viruses.
目前市面上的抗病毒藥物大多屬於「窄譜」型，意即它們僅針對單一病毒進行防禦。
Most antivirals available today are "narrow-spectrum," meaning they are designed to fight only one specific virus.
然而，研究人員正在追求一項重大突破：廣譜抗病毒藥物。
However, researchers are now pursuing a breakthrough: a broad-spectrum antiviral.
一項 2025 年的重要研究提出了一種潛在解決方案，即針對聚糖（醣類分子），這種分子存在於許多病毒表面。
A major 2025 study highlighted a potential solution by targeting glycans—sugar molecules found on the surface of many viruses.
科學家透過合成碳水化合物受體來「鉗住」這些糖類，成功阻斷了多個病毒家族的感染，其中包括伊波拉病毒與新冠病毒（SARS-CoV-2）。
By using synthetic carbohydrate receptors to "clamp" onto these sugars, scientists successfully blocked infection across multiple viral families, including Ebola and SARS-CoV-2.
另一項有前景的策略涉及「宿主標靶」，這能阻斷病毒藉以複製的內部機制。
Another promising strategy involves host-targeting, which blocks the internal machinery that viruses hijack to replicate.
由於病毒依賴這些人類細胞過程，它們難以通過突變來規避這種治療。
Since viruses rely on these human cell processes, they cannot easily mutate to bypass the treatment.
雖然我們仍處於實驗階段，但這些進展代表了大流行防備方面的重大轉變。
While we are still in the experimental stage, these advancements represent a significant shift in pandemic preparedness.
雖然它們還不是您在家附近藥局就能買到的「萬靈丹」或「神奇子彈」，但這項研究帶領我們邁向一個未來：我們不再需要為了應對新威脅而等待數年去研發專一的病毒疫苗。
While not a "magic bullet" available at your local pharmacy just yet, this research brings us closer to a future where we no longer have to wait years for a virus-specific vaccine to combat a new threat.
